Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysis

Isavuconazole exposure in the ICU was suboptimal with high pharmacokinetic variability. Pending external validation, isavuconazole concentrations should be monitored, and higher dosing regimens considered at treatment initiation.